Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biogen Inc (BIIB)

Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 25,977,990
  • Shares Outstanding, K 146,702
  • Annual Sales, $ 9,676 M
  • Annual Income, $ 1,632 M
  • EBIT $ 2,735 M
  • EBITDA $ 3,698 M
  • 60-Month Beta 0.13
  • Price/Sales 2.67
  • Price/Cash Flow 7.63
  • Price/Book 1.42

Options Overview Details

View History
  • Implied Volatility 29.27% (-3.90%)
  • Historical Volatility 26.29%
  • IV Percentile 3%
  • IV Rank 3.73%
  • IV High 64.86% on 04/09/25
  • IV Low 27.89% on 02/13/25
  • Expected Move (DTE 4) 4.00 (2.26%)
  • Put/Call Vol Ratio 0.18
  • Today's Volume 1,020
  • Volume Avg (30-Day) 1,790
  • Put/Call OI Ratio 0.73
  • Today's Open Interest 68,964
  • Open Int (30-Day) 76,474
  • Expected Range 173.09 to 181.08

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 33 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 1.73
  • Number of Estimates 25
  • High Estimate 3.54
  • Low Estimate 1.30
  • Prior Year 3.44
  • Growth Rate Est. (year over year) -49.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
168.56 +5.05%
on 12/18/25
183.15 -3.31%
on 12/05/25
-4.86 (-2.67%)
since 11/26/25
3-Month
135.39 +30.79%
on 09/29/25
185.17 -4.37%
on 11/24/25
+39.71 (+28.91%)
since 09/26/25
52-Week
110.04 +60.92%
on 04/09/25
185.17 -4.37%
on 11/24/25
+27.18 (+18.13%)
since 12/26/24

Most Recent Stories

More News
The Journal of the American Medical Association (JAMA) Neurology Publishes Long Term Results from the QALSODY Phase 3 VALOR Study and its Open-Label Extension in SOD1-ALS

Long-term data published in JAMA Neurology further illustrate the effects of Biogen’s QALSODY on function, strength, and survival in SOD1 -ALS Over 3 years, a subset of QALSODY-treated participants...

BIIB : 177.08 (+0.43%)
Therapeutics Stocks Q3 In Review: Biogen (NASDAQ:BIIB) Vs Peers

Therapeutics Stocks Q3 In Review: Biogen (NASDAQ:BIIB) Vs Peers

BIIB : 177.08 (+0.43%)
Biogen (BIIB) Stock Trades Up, Here Is Why

Biogen (BIIB) Stock Trades Up, Here Is Why

BIIB : 177.08 (+0.43%)
1 Nasdaq 100 Stock Worth Your Attention and 2 Facing Headwinds

1 Nasdaq 100 Stock Worth Your Attention and 2 Facing Headwinds

KDP : 28.10 (+0.36%)
DASH : 233.95 (+0.81%)
BIIB : 177.08 (+0.43%)
MicroStrategy Gets to Stay in the Nasdaq-100. Does It Deserve to Stay in Your Portfolio Too?

MSTR was being eyed for possible Nasdaq-100 removal, but when the index reconstitutes next week, it will get to stay. Other companies, including Biogen and Lululemon, will be removed.

MSTR : 158.81 (+0.06%)
LULU : 208.97 (-0.68%)
^BTCUSD : 87,282.00 (-0.21%)
BIIB : 177.08 (+0.43%)
3 Mid-Cap Stocks We Find Risky

3 Mid-Cap Stocks We Find Risky

VLTO : 101.75 (-0.53%)
FLEX : 63.33 (-0.35%)
BIIB : 177.08 (+0.43%)
3 Healthcare Stocks We Think Twice About

3 Healthcare Stocks We Think Twice About

EVH : 4.12 (-0.24%)
BLCO : 17.18 (+1.00%)
BIIB : 177.08 (+0.43%)
Fed Cuts Rates for Third Time This Year, Signals One More in 2026

The S&P 500 Index ($SPX ) (SPY ) today is down up +0.34%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.67%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.01%. In a divided vote,...

MSTR : 158.81 (+0.06%)
TROW : 104.75 (+0.07%)
GLXY : 23.40 (-4.22%)
WAT : 386.06 (+0.32%)
$IUXX : 25,644.39 (-0.05%)
DASH : 233.95 (+0.81%)
COIN : 236.90 (-1.18%)
ZNH26 : 112-230 (+0.12%)
CHWY : 32.49 (+1.69%)
$DOWI : 48,710.97 (-0.04%)
^BTCUSD : 87,282.00 (-0.21%)
SPY : 690.31 (-0.01%)
Stocks Pressured by Higher Bond Yields

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.01%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.03%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.26%. December E-mini S&P...

MSTR : 158.81 (+0.06%)
TROW : 104.75 (+0.07%)
CBRL : 25.95 (-1.74%)
GLXY : 23.40 (-4.22%)
WAT : 386.06 (+0.32%)
$IUXX : 25,644.39 (-0.05%)
COIN : 236.90 (-1.18%)
ZNH26 : 112-230 (+0.12%)
ESH26 : 6,964.00 (-0.22%)
CHWY : 32.49 (+1.69%)
$DOWI : 48,710.97 (-0.04%)
^BTCUSD : 87,282.00 (-0.21%)
Is Biogen Stock Outperforming the Dow?

Biogen has notably outpaced the Dow in recent months and over the past year, and analysts remain moderately bullish on the stock’s prospects.

SRPT : 22.12 (-0.90%)
$DOWI : 48,710.97 (-0.04%)
BIIB : 177.08 (+0.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Biogen Inc. is one of the world's leading biotechnology companies which focuses on developing innovative therapies for treating serious neurological and neurodegenerative diseases, including its core growth areas of multiple sclerosis (MS) and neuroimmunology, Alzheimer's disease (AD) and dementia, movement...

See More

Key Turning Points

3rd Resistance Point 180.04
2nd Resistance Point 178.61
1st Resistance Point 177.85
Last Price 177.08
1st Support Level 175.66
2nd Support Level 174.23
3rd Support Level 173.47

See More

52-Week High 185.17
Last Price 177.08
Fibonacci 61.8% 156.47
Fibonacci 50% 147.60
Fibonacci 38.2% 138.74
52-Week Low 110.04

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar